Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD27 antibodies and uses thereof

Anti-CD27 antibodies and uses thereof

US Patent 12110337 · Granted Oct 8, 2024

Estimated economic value: $338,352,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glypican-3-binding fibronectin based scaffold molecules2025
Activatable anti-CTLA-4 antibodies and uses thereof2025
Engineered CD25 polypeptides and uses thereof2025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Anti-interleukin-23 P19 antibodies and methods of use thereof2025
mRNA vaccine encoding fusion antigen against Mpox and severe acute respiratory s2025
Antibodies against TIM3 and uses thereof2025